Antineoplastic effects of Magnoliae officinalis in tumours other than hepatomas
First published: 05 June 2009
No abstract is available for this article.
References
- 1
Deng J,
Qian Y,
Geng L, et al. Involvement of p38 mitogen-activated protein kinase pathway in honokiol-induced apoptosis in a human hepatoma cell line (hepG2).
Liver Int
2008; 28: 1458–64.
- 2
Jiang QQ,
Fan LY,
Yang GL, et al. Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model.
BMC Cancer
2008; 8: 242.
- 3
Hahm ER,
Arlotti JA,
Marynowski SW,
Singh SV.
Honokiol, a constituent of oriental medicinal herb Magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
Clin Cancer Res
2008; 14: 1248–57.
- 4
Kim BH,
Cho JY.
Anti-inflammatory effect of honokiol is mediated by PI3K/Akt pathway suppression.
Acta Pharmacol Sin
2008; 29: 113–22.
- 5
Liu H,
Zang C,
Emde A, et al. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
Eur J Pharmacol
2008; 591: 43–51.
- 6
Chan LW,
Cheah EL,
Saw CL,
Weng W,
Heng PW.
Antimicrobial and antioxidant activities of Cortex Magnoliae officinalis and some other medicinal plants commonly used in South-East Asia.
Chin Med
2008; 3: 15.
- 7
Lee SJ,
Park SS,
Lee US,
Kim WJ,
Moon SK.
Signaling pathway for TNF-alpha-induced MMP-9 expression: mediation through p38 MAP kinase, and inhibition by anti-cancer molecule magnolol in human urinary bladder cancer 5637 cells.
Int Immunopharmacol
2008; 8: 1821–6.
- 8
Fong WF,
Tse AK,
Poon KH,
Wang C.
Magnolol and honokiol enhance HL-60 human leukemia cell differentiation induced by 1,25-dihydroxyvitamin D3 and retinoic acid.
Int J Biochem Cell Biol
2005; 37: 427–41.
